Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anthracycline associated cardiotoxicity in survivors of childhood cancer.

Literature DB >> 18347383

Anthracycline associated cardiotoxicity in survivors of childhood cancer.

Steven E Lipshultz¹, Jorge A Alvarez, Rebecca E Scully.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2008 PMID： 18347383 DOI： 10.1136/hrt.2007.136093

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

Keyword Cloud
Cited

× No keyword cloud information.

115 in total

1. A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study.

Authors: Ashok J Theruvath; Anat Ilivitzki; Anne Muehe; Johanna Theruvath; Praveen Gulaka; Christine Kim; Sandra Luna-Fineman; Kathleen M Sakamoto; Kristen W Yeom; Phillip Yang; Michael Moseley; Frandics Chan; Heike E Daldrup-Link
Journal: Radiology Date: 2017-08-04 Impact factor: 11.105

2. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT.

Authors: K P Daly; S D Colan; E D Blume; R Margossian; K Gauvreau; C Duncan; L E Lehmann; M H Chen
Journal: Bone Marrow Transplant Date: 2011-01-31 Impact factor: 5.483

3. Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.

Authors: Asimina Hiona; Andrew Stephen Lee; Jayan Nagendran; Xiaoyan Xie; Andrew J Connolly; Robert C Robbins; Joseph C Wu
Journal: J Thorac Cardiovasc Surg Date: 2010-11-20 Impact factor: 5.209

Review 4. Early detection of chemotherapy-related left ventricular dysfunction.

Authors: Jeanne M DeCara
Journal: Curr Cardiol Rep Date: 2012-06 Impact factor: 2.931

5. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.

Authors: Ana Maria Segura; Rajko Radovancevic; Zumrat T Demirozu; O H Frazier; L Maximilian Buja
Journal: Tex Heart Inst J Date: 2015-04-01

6. AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.

Authors: Todd M Cooper; Todd A Alonzo; Robert B Gerbing; John P Perentesis; James A Whitlock; Jeffrey W Taub; Terzah M Horton; Alan S Gamis; Soheil Meshinchi; Michael R Loken; Bassem I Razzouk
Journal: Cancer Date: 2014-04-25 Impact factor: 6.860

Anthracycline associated cardiotoxicity in survivors of childhood cancer.

1. A PET/MR Imaging Approach for the Integrated Assessment of Chemotherapy-induced Brain, Heart, and Bone Injuries in Pediatric Cancer Survivors: A Pilot Study.

2. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT.

3. Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.

Review 4. Early detection of chemotherapy-related left ventricular dysfunction.

5. Anthracycline treatment and ventricular remodeling in left ventricular assist device patients.

6. AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.

7. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity.

Review 8. Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes.

9. Anthracycline cardiotoxicity: from bench to bedside.

Review 10. Cardio-toxicity in childhood cancer survivors "Cure is not enough".